
| Cat. No. |
Size |
Price |
Figures |
RP12817-5 mg
| 5 mg | $ 42.75 | HPLC: 20060721145623 (PDF) MS: 20060721145603 (PDF) MSDS: 20080703044506 (PDF)
References:
- Huang L, et al. Novel peptide inhibitors of angiotensin-converting enzyme 2. J Biol Chem. May 2003; 278(18): 15532-15540.
- Campbell DJ, et al. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease. Circulation. Jul 2005; 112(1): 110-116.
- Pilz B, et al. Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats. Hypertension. Sep 2005; 46(3): 569-576.
|
|---|
| Full Name | |
Sequence (one-letter code) |
HPFHLlVY | Sequence (three-letter code) | {HIS}{PRO}{PHE}{HIS}{LEU}{d-LEU}{VAL}{TYR} | | Description | Renin inhibitors have been pursued as potential new cardiovascular medications since the early-1980s. Renin inhibitors are usually considered as a ‘holy grail’ of antihypertensive therapy, because they interact with the renin-angiotensin system (RAS) that governs blood pressure.
|
|---|
| Formula | C52H72N12O10 | | M.W. | 1025.21 | | Purity | > 95% | | Storage | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
| * For Non-Clinical Research Use Only *If you cannot find your peptides on our list, try our Express PeptideTM Service, and receive high-quality peptides in eight business days, guaranteed. Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance.
|
|